Literature DB >> 31771866

Extensive financial hardship among gynecologic cancer patients starting a new line of therapy.

Margaret I Liang1, Maria Pisu2, Sarah S Summerlin3, Teresa K L Boitano4, Christina T Blanchard5, Smita Bhatia6, Warner K Huh7.   

Abstract

OBJECTIVE: Our objective was to evaluate the three domains of financial hardship (psychological response, material conditions, and coping behaviors) among gynecologic cancer patients receiving treatment.
METHODS: We conducted a single-institution survey of gynecologic cancer patients starting a new line of therapy for primary or recurrent disease. Psychological response was measured using Comprehensive Score for Financial Toxicity, with score < 26 indicating financial distress. We measured material conditions by patient-reported changes in employment or spending and coping behaviors by patient-reported medication non-adherence. We performed descriptive statistics, bivariate analysis, and multivariate logistic regression.
RESULTS: Among 121 participants, the mean age was 59 years, 28% were African-American, 50% reported income < $40,000, 74% had private insurance, 20% had only public insurance, and 7% were uninsured. Sixty-five (54%) participants screened positive for financial distress. Age < 65 years (aOR 2.61, 95% CI 1.04-6.52) and income < $40,000 (aOR 3.41, 95% CI 1.28-9.09) were associated with increased odds of screening positive for financial distress. Participants with financial distress were significantly more likely to report material hardship, including losing wages (46% vs. 18%, p < 0.01), not paying bills on time (40% vs. 7%, p < 0.01), and borrowing money (39% vs. 4%, p < 0.01). Financial distress was not associated with coping behaviors, such as not taking (6% vs. 2%, p = 0.37) or refilling medications (5% vs. 2%, p = 0.62).
CONCLUSIONS: Financial distress affects over half of gynecologic cancer patients starting a new line of treatment and is associated with material hardship. Younger age and lower income can be used to identify patients at increased risk.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Costs of care; Financial hardship; Financial toxicity; Gynecologic cancer

Mesh:

Year:  2019        PMID: 31771866      PMCID: PMC7018550          DOI: 10.1016/j.ygyno.2019.11.022

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  10 in total

1.  Utilization of an Electronic Patient-Reported Outcome Platform to Evaluate the Psychosocial and Quality-of-Life Experience Among a Community Sample of Ovarian Cancer Survivors.

Authors:  Fay J Hlubocky; Christopher K Daugherty; Jeffery Peppercorn; Karen Young; Kristen E Wroblewski; Seiko Diane Yamada; Nita K Lee
Journal:  JCO Clin Cancer Inform       Date:  2022-08

2.  Patient-reported benefit from proposed interventions to reduce financial toxicity during cancer treatment.

Authors:  Emeline M Aviki; Bridgette Thom; Kenya Braxton; Andrew J Chi; Beryl Manning-Geist; Fumiko Chino; Carol L Brown; Nadeem R Abu-Rustum; Francesca M Gany
Journal:  Support Care Cancer       Date:  2021-11-25       Impact factor: 3.359

3.  Piloting use of an out-of-pocket cost tracker among gynecologic cancer patients.

Authors:  Margaret I Liang; Sarah S Summerlin; Teresa K L Boitano; Christina T Blanchard; Warner K Huh; Smita Bhatia; Maria Pisu
Journal:  Gynecol Oncol Rep       Date:  2022-05-11

4.  Financial toxicity: An adverse effect worthy of a black box warning?

Authors:  Joseph A Dottino; J Alejandro Rauh-Hain
Journal:  Gynecol Oncol       Date:  2020-02       Impact factor: 5.482

5.  Patient cost sharing during poly(adenosine diphosphate-ribose) polymerase inhibitor treatment in ovarian cancer.

Authors:  Ross F Harrison; Shuangshuang Fu; Charlotte C Sun; Hui Zhao; Karen H Lu; Sharon H Giordano; Larissa A Meyer
Journal:  Am J Obstet Gynecol       Date:  2021-02-04       Impact factor: 10.693

6.  Measuring Financial Distress and Quality of Life Over Time in Patients With Gynecologic Cancer-Making the Case to Screen Early in the Treatment Course.

Authors:  Margaret I Liang; Sarah S Summerlin; Christina T Blanchard; Teresa K L Boitano; Warner K Huh; Smita Bhatia; Maria Pisu
Journal:  JCO Oncol Pract       Date:  2021-02-17

7.  Assessment of Financial Toxicity Among Older Adults With Advanced Cancer.

Authors:  Asad Arastu; Arpan Patel; Supriya Gupta Mohile; Joseph Ciminelli; Ramya Kaushik; Megan Wells; Eva Culakova; Lianlian Lei; Huiwen Xu; David W Dougherty; Mostafa R Mohamed; Elaine Hill; Paul Duberstein; Marie Anne Flannery; Charles Stewart Kamen; Chintan Pandya; Jeffrey L Berenberg; Valerie G Aarne Grossman; Yang Liu; Kah Poh Loh
Journal:  JAMA Netw Open       Date:  2020-12-01

8.  A qualitative study on the impact of long-distance travel for gynecologic cancer care.

Authors:  Vaidehi Mujumdar; Timberly R Butler; David I Shalowitz
Journal:  Gynecol Oncol Rep       Date:  2021-09-25

9.  Financial toxicity in patients with gynecologic malignancies: a cross sectional study.

Authors:  Burak Zeybek; Emily Webster; Natalia Pogosian; Joan Tymon-Rosario; Alan Balch; Gary Altwerger; Mitchell Clark; Gulden Menderes; Gloria Huang; Masoud Azodi; Elena S Ratner; Peter E Schwartz; Alessandro D Santin; Vaagn Andikyan
Journal:  J Gynecol Oncol       Date:  2021-07-23       Impact factor: 4.401

10.  Financial toxicity in female patients with breast cancer: a national cross-sectional study in China.

Authors:  Meicen Liu; Linlin Hu; Xueyan Han; Man Cao; Jing Sun; Yuanli Liu
Journal:  Support Care Cancer       Date:  2022-07-11       Impact factor: 3.359

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.